Datamonitor’s Pharmaceuticals: China Industry Guide is an essential resource for top-level data and analysis covering the China Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The Chinese pharmaceuticals market generated total revenues of $23,796.9 million in 2009, representing a compound annual growth rate (CAGR) of 20.1% for the period spanning 2005-2009.
* The Chinese OTC pharmaceuticals market generated total revenues of $8.2 billion in 2008, representing a compound annual growth rate (CAGR) of 6.8% for the period spanning 2004-2008.
* The Chinese biotechnology market generated total revenues of $6.3 billion in 2008, representing a compound annual growth rate (CAGR) of 18.1% for the period spanning 2004-2008.
* The Chinese generics market generated total revenues of $22.7 billion in 2008, representing a compound annual growth rate (CAGR) of 19.5% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
CHAPTER 1 BIOTECHNOLOGY IN CHINA 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 14
1.5 Five Forces Analysis 15
1.6 Market Forecasts 21
CHAPTER 2 GENERICS IN CHINA 22
2.1 Market Overview 22
2.2 Market Value 24
2.3 Market Segmentation I 25
2.4 Market Segmentation II 26
2.5 Five Forces Analysis 27
2.6 Market Forecasts 34
CHAPTER 3 OTC PHARMACEUTICALS IN CHINA 35
3.1 Market Overview 35
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4 Market Segmentation II 39
3.5 Market Share 40
3.6 Five Forces Analysis 41
3.7 Distribution 50
3.8 Market Forecasts 51
CHAPTER 4 PHARMACEUTICALS IN CHINA 52
4.1 Market Overview 52
4.2 Market Value 54
4.3 Market Segmentation I 55
4.4 Market Segmentation II 56
4.5 Market Share 57
4.6 Five Forces Analysis 58
4.7 Market Forecasts 65
CHAPTER 5 MACROECONOMIC INDICATORS 66
CHAPTER 6 APPENDIX 68
6.1 Data Research Methodology 68
LIST OF TABLES
Table 1: China Biotechnology Market Value: $ billion, 2004-2008 12
Table 2: China Biotechnology Market Segmentation I: % Share, by Value, 2008 13
Table 3: China Biotechnology Market Segmentation II: % Share, by Value, 2008 14
Table 4: China Biotechnology Market Value Forecast: $ billion, 2008-2013 21
Table 5: China Generics Market Value: $ billion, 2004-2008 24
Table 6: China Generics Market Segmentation I: % Share, by Value, 2008 25
Table 7: China Generics Market Segmentation II: % Share, by Value, 2008 26
Table 8: China Generics Market Value Forecast: $ billion, 2008-2013 34
Table 9: China OTC Pharmaceuticals Market Value: $ billion, 2004-2008 37
Table 10: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 38
Table 11: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 39
Table 12: China OTC Pharmaceuticals Market Share: % Share, by Value, 2008 40
Table 13: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008 50
Table 14: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 51
Table 15: China Pharmaceuticals Market Value: $ billion, 2005-2009 54
Table 16: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 55
Table 17: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 56
Table 18: China Pharmaceuticals Market Share: % Share, by Value, 2009 57
Table 19: China Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 65
Table 20: China Size of Population (million) , 2004-2008 66
Table 21: China GDP (Constant 2000 Prices, $ billion), 2004-2008 66
Table 22: China Inflation, 2004-2008 67
Table 23: China Exchange Rate, 2004-2008 67
LIST OF FIGURES
Figure 1: China Biotechnology Market Value: $ billion, 2004-2008 12
Figure 2: China Biotechnology Market Segmentation I: % Share, by Value, 2008 13
Figure 3: China Biotechnology Market Segmentation II: % Share, by Value, 2008 14
Figure 4: Forces Driving Competition in the Biotechnology Market in China, 2008 15
Figure 5: Drivers of Buyer Power in the Biotechnology Market in China, 2008 16
Figure 6: Drivers of Supplier Power in the Biotechnology Market in China, 2008 17
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in China, 2008 18
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in China, 2008 19
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in China, 2008 20
Figure 10: China Biotechnology Market Value Forecast: $ billion, 2008-2013 21
Figure 11: China Generics Market Value: $ billion, 2004-2008 24
Figure 12: China Generics Market Segmentation I: % Share, by Value, 2008 25
Figure 13: China Generics Market Segmentation II: % Share, by Value, 2008 26
Figure 14: Forces Driving Competition in the Generics Market in China, 2008 27
Figure 15: Drivers of Buyer Power in the Generics Market in China, 2008 29
Figure 16: Drivers of Supplier Power in the Generics Market in China, 2008 30
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in China, 2008 31
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in China, 2008 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in China, 2008 33
Figure 20: China Generics Market Value Forecast: $ billion, 2008-2013 34
Figure 21: China OTC Pharmaceuticals Market Value: $ billion, 2004-2008 37
Figure 22: China OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008 38
Figure 23: China OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008 39
Figure 24: China OTC Pharmaceuticals Market Share: % Share, by Value, 2008 40
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in China, 2008 41
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in China, 2008 43
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in China, 2008 44
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in China, 2008 45
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in China, 2008 47
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in China, 2008 48
Figure 31: China OTC Pharmaceuticals Distribution: % Share, by Value, 2008 50
Figure 32: China OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 51
Figure 33: China Pharmaceuticals Market Value: $ billion, 2005-2009 54
Figure 34: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2009 55
Figure 35: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2009 56
Figure 36: China Pharmaceuticals Market Share: % Share, by Value, 2009 57
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in China, 2009 58
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in China, 2009 60
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in China, 2009 61
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in China, 2009 62
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in China, 2009 63
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in China, 2009 64
Figure 43: China Pharmaceuticals Market Value Forecast: $ billion, 2009-2014 65
Other selected research from the 'China' category:
Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment